Verapamil reduces tachycardia-induced electrical remodeling of the atria.

BACKGROUND Prolonged periods of atrial fibrillation or rapid atrial pacing induce shortening of the atrial effective refractory period (AERP), which is thought to be related to the lower success rates of various antifibrillatory treatments when the arrhythmia has lasted for a longer period of time. METHODS AND RESULTS To investigate whether an increase in intracellular calcium could be the stimulus for electrical remodeling, the effects of verapamil on shortening of the AERP in response to 24 hours of rapid atrial pacing (300 bpm) were studied in five chronically instrumented conscious goats during infusion of saline or verapamil. During rapid atrial pacing, the ventricular rate was kept constant by ventricular pacing (150 bpm). The AERP was measured by programmed electrical stimulation at basic cycle lengths of 430, 300, and 200 ms. Verapamil had no effects on the AERP before rapid atrial pacing. However, in the course of 24 hours of rapid atrial pacing, the AERP shortened significantly less (27% to 58%) in the presence of verapamil compared with control (at 430, 300, and 200 ms, P < .001, P < .01, and P < .01, respectively). Also, after cessation of pacing, complete recovery of the AERP during verapamil infusion occurred much sooner than in the control experiments. Despite a significant reduction in electrical remodeling, there was only a minimal reduction in inducibility of atrial fibrillation by verapamil (34% versus 39% in the control experiments, P = .03). CONCLUSIONS Electrical remodeling of the atrium during rapid atrial pacing was significantly attenuated by verapamil. This suggests that electrical remodeling of the atrium is triggered by the high calcium influx during rapid atrial pacing rates.

[1]  H. C. Hartzell,et al.  Regulation of cardiac ion channels by catecholamines, acetylcholine and second messenger systems. , 1988, Progress in biophysics and molecular biology.

[2]  M. Shenasa,et al.  Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. , 1988, The American journal of cardiology.

[3]  S Nattel,et al.  Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. , 1993, Circulation.

[4]  G. M. Briggs,et al.  Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. , 1990, The Journal of clinical investigation.

[5]  M. Eichelbaum,et al.  Diltiazem, Verapamil, and Quinidine in Patients With Chronic Atrial Fibrillation , 1985, Journal of clinical pharmacology.

[6]  J. Talano,et al.  Atrial fibrillation and flutter. Immediate control and conversion with intravenously administered verapamil. , 1983, Archives of internal medicine.

[7]  G. Moe,et al.  On the multiple wavelet hypothesis o f atrial fibrillation. , 1962 .

[8]  T. Pop,et al.  The Prognostic Value of Right Atrium Monophasic Action Potential after Conversion of Atrial Fibrillation , 1972, European journal of clinical investigation.

[9]  I. V. Van Gelder,et al.  Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens. , 1988, European heart journal.

[10]  S. Lemaire,et al.  High frequency-induced upregulation of human cardiac calcium currents. , 1996, Circulation.

[11]  P B Corr,et al.  The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. , 1991, The Journal of thoracic and cardiovascular surgery.

[12]  W. Wier,et al.  Intracellular calcium transients underlying the short‐term force‐interval relationship in ferret ventricular myocardium. , 1986, The Journal of physiology.

[13]  B. Singh,et al.  Use of calcium antagonists for cardiac arrhythmias. , 1987, The American journal of cardiology.

[14]  K. Lie,et al.  The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. , 1990, Journal of the American College of Cardiology.

[15]  Josep Brugada,et al.  Regional Entrainment of Atrial Fibrillation Studied by High‐Resolution Mapping in Open‐Chest Dogs , 1993, Circulation.

[16]  D. Noble,et al.  Use‐dependent reduction and facilitation of Ca2+ current in guinea‐pig myocytes. , 1988, The Journal of physiology.

[17]  A. Zygmunt,et al.  Properties of the calcium-activated chloride current in heart , 1992, The Journal of general physiology.

[18]  M. Allessie,et al.  Length of Excitation Wave and Susceptibility to Reentrant Atrial Arrhythmias in Normal Conscious Dogs , 1988, Circulation research.

[19]  J. Jalife,et al.  Cardiac Electrophysiology: From Cell to Bedside , 1990 .

[20]  I C van Gelder,et al.  UvA-DARE ( Digital Academic Repository ) Efficacy , safety , and determinants of conversion of atrial fibrillation and flutter with oral amiodarone , 1997 .

[21]  K. S. Lee.  Potentiation of the calcium-channel currents of internally perfused mammalian heart cells by repetitive depolarization. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Allessie,et al.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.

[23]  A. Zygmunt,et al.  Calcium-activated chloride current in rabbit ventricular myocytes. , 1991, Circulation research.

[24]  D. Krikler,et al.  Immediate Effects of Intravenous Verapamil in Cardiac Arrhythmias , 1972, British medical journal.

[25]  J. Willerson,et al.  Intracellular calcium transients and arrhythmia in isolated heart cells. , 1991, Circulation research.

[26]  W. Kannel,et al.  Epidemiologic features of chronic atrial fibrillation: the Framingham study. , 1982, The New England journal of medicine.

[27]  S. Olsson,et al.  Monophasic action potential and sinus rhythm stability after conversion of atrial fibrillation. , 2009, Acta medica Scandinavica.

[28]  A ROSENBLUETH,et al.  The mathematical formulation of the problem of conduction of impulses in a network of connected excitable elements, specifically in cardiac muscle. , 1946, Archivos del Instituto de Cardiologia de Mexico.

[29]  C. Mcpherson,et al.  ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage. , 1991 .

[30]  R. Kerber,et al.  The Effects of Atrial Fibrillation on Atrial Pressure‐ Volume and Flow Relationships , 1982, Circulation research.

[31]  H. Mcintosh,et al.  Electrical Conversion of Atrial Fibrillation: Immediate and Long-term Results and Selection of Patients , 1966 .

[32]  F. Epstein,et al.  Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. , 1991, The New England journal of medicine.

[33]  S. Bertil Olsson,et al.  Atrial Fibrillation: Mechanisms and Therapeutic Strategies , 1994 .

[34]  J. Kingma,et al.  Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. , 1989, The American journal of cardiology.

[35]  G. Christensen,et al.  Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644. , 1996, Circulation.

[36]  B. Lown.  Electrical reversion of cardiac arrhythmias. , 1967, British heart journal.

[37]  H. Ikram,et al.  Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm. , 1987, The American journal of cardiology.

[38]  Magnus Holm,et al.  Determination of Preferable Directions of Impulse Propagation during Atrial Fibrillation by Time Averaging of Multiple Electrogram Vectors , 1994 .

[39]  M. Allessie,et al.  The Wavelength of the Cardiac Impulse and Reentrant Arrhythmias in Isolated Rabbit Atrium: The Role of Heart Rate, Autonomic Transmitters, Temperature, and Potassium , 1986, Circulation research.

[40]  O. Orning,et al.  An evaluation of DC shock treatment of atrial arrhythmias. , 2009, Acta medica Scandinavica.

[41]  J A ABILDSKOV,et al.  Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. , 1959, American heart journal.

[42]  J. Godtfredsen.  Atrial fibrillation : etiology, course, and prognosis : a follow-up study of 1212 cases , 1975 .

[43]  E. Kaplinsky,et al.  The beneficial effects of verapamil in chronic atrial fibrillation. , 1979, Archives of internal medicine.

[44]  N. Kouchoukos,et al.  Verapamil therapy of atrial fibrillation and atrial flutter following cardiac operation. , 1982, The Journal of thoracic and cardiovascular surgery.

[45]  H C Lee,et al.  Cytosolic calcium staircase in cultured myocardial cells. , 1987, Circulation research.

[46]  P. Coumel,et al.  FAILURE IN THE RATE ADAPTATION OF THE ATRIAL REFRACTORY PERIODS: NEW PARAMETER TO ASSESS ATRIAL VULNERABILTTY , 1984 .

[47]  H. Crijns,et al.  Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. , 1991, The American journal of cardiology.

[48]  H. Irisawa,et al.  Intracellular Ca2+ and protein kinase C modulate K+ current in guinea pig heart cells. , 1987, The American journal of physiology.

[49]  S Nattel,et al.  Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation. , 1992, Circulation research.

[50]  L. Mcdonald,et al.  Appraisal of electroconversion in treatment of cardiac dysrhythmias. , 1968, British heart journal.

[51]  P. Coumel,et al.  The Atrium in health and disease , 1989 .

[52]  J. Maylie,et al.  Stimulation‐dependent facilitation of the high threshold calcium current in guinea‐pig ventricular myocytes. , 1990, The Journal of physiology.

[53]  D. Duncker,et al.  Rapid ventricular pacing produces myocardial protection by nonischemic activation of KATP+ channels. , 1996, Circulation.

[54]  R. Tsien,et al.  Mechanisms of calcium channel modulation by beta-adrenergic agents and dihydropyridine calcium agonists. , 1986, Journal of molecular and cellular cardiology.

[55]  B. Gersh,et al.  The natural history of lone atrial fibrillation. A population-based study over three decades. , 1987, The New England journal of medicine.

[56]  R. Sung,et al.  Intravenous verapamil for termination of re-entrant supraventricular tachycardias: intracardiac studies correlated with plasma verapamil concentrations. , 1980, Annals of internal medicine.

[57]  G. Tseng.  Calcium Current Restitution in Mammalian Ventricular Myocytes is Modulated by Intracellular Calcium , 1988, Circulation research.

[58]  M. Allessie,et al.  High-density mapping of electrically induced atrial fibrillation in humans. , 1994, Circulation.

[59]  P. T. Onundarson,et al.  Chronic atrial fibrillation--epidemiologic features and 14 year follow-up: a case control study. , 1987, European heart journal.

[60]  W. Rheinboldt,et al.  A COMPUTER MODEL OF ATRIAL FIBRILLATION. , 1964, American heart journal.

[61]  A. Noma,et al.  ATP-regulated K+ channels in cardiac muscle , 1983, Nature.

[62]  P. Coumel,et al.  Failure in the rate adaptation of the atrial refractory period: its relationship to vulnerability. , 1982, International journal of cardiology.

[63]  S. Noble,et al.  The calcium and frequency dependence of the slow inward current ‘staircase’ in frog atrium. , 1981, The Journal of physiology.

[64]  R. Sung,et al.  Verapamil for Control of Ventricular Rate in Paroxysmal Supraventricular Tachycardia and Atrial Fibrillation or Flutter: A Double-Blind Randomized Cross-Over Study , 2020 .

[65]  E. Marbán,et al.  Cell calcium in the pathophysiology of ventricular fibrillation and in the pathogenesis of postarrhythmic contractile dysfunction. , 1989, Circulation.

[66]  José Jalife,et al.  Cardiac electrophysiology and arrhythmias , 1985 .

[67]  M. Holtzman,et al.  Induction of epithelial arachidonate 12-lipoxygenase at active sites of inflammatory bowel disease. , 1993, The American journal of physiology.

[68]  I. V. Van Gelder,et al.  Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. , 1991, The American journal of cardiology.

[69]  E. Prystowsky,et al.  Effects of Intravenous and Chronic Oral Verapamil Administration in Patients with Supraventricular Tachyarrhythmias , 1980, Circulation.

[70]  Douglas L. Jones,et al.  Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. , 1995, Circulation.

[71]  H. Crijns,et al.  Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. , 1993, The American journal of cardiology.